The stock price of Caredx Inc (NASDAQ: CDNA) has dropped by -0.13 compared to previous close of 22.93. Despite this, the company has seen a gain of 1.33% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-04 that CareDx, Inc (NASDAQ:CDNA ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Greg Chodaczek – Managing Director John Hanna – President and Chief Executive Officer Abhishek Jain – Chief Financial Officer Conference Call Participants Bill Bonello – Craig-Hallum Mark Massaro – BTIG Brandon Couillard – Wells Fargo Yi Chen – H.C. Wainwright Mason Carrico – Stephens Inc Thomas DeBourcy – Nephron Research Operator Good day, everyone, and welcome to today’s CareDx, Inc. Third Quarter 2024 Earnings Conference Call.
Is It Worth Investing in Caredx Inc (NASDAQ: CDNA) Right Now?
The stock has a 36-month beta value of 1.84. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CDNA is 49.35M, and at present, short sellers hold a 7.04% of that float. On November 06, 2024, the average trading volume of CDNA was 911.86K shares.
CDNA’s Market Performance
CDNA stock saw a decrease of 1.33% in the past week, with a monthly decline of -28.88% and a quarterly a decrease of -5.68%. The volatility ratio for the week is 6.13%, and the volatility levels for the last 30 days are 6.94% for Caredx Inc (CDNA). The simple moving average for the last 20 days is -7.60% for CDNA’s stock, with a simple moving average of 31.08% for the last 200 days.
Analysts’ Opinion of CDNA
Many brokerage firms have already submitted their reports for CDNA stocks, with Wells Fargo repeating the rating for CDNA by listing it as a “Underweight.” The predicted price for CDNA in the upcoming period, according to Wells Fargo is $28 based on the research report published on August 28, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see CDNA reach a price target of $40. The rating they have provided for CDNA stocks is “Buy” according to the report published on August 19th, 2024.
CDNA Trading at -17.39% from the 50-Day Moving Average
After a stumble in the market that brought CDNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.27% of loss for the given period.
Volatility was left at 6.94%, however, over the last 30 days, the volatility rate increased by 6.13%, as shares sank -28.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.12% lower at present.
During the last 5 trading sessions, CDNA rose by +1.33%, which changed the moving average for the period of 200-days by +133.44% in comparison to the 20-day moving average, which settled at $24.78. In addition, Caredx Inc saw 90.83% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDNA starting from Johnson Alexander L, who sale 39,466 shares at the price of $33.17 back on Aug 20 ’24. After this action, Johnson Alexander L now owns 284,983 shares of Caredx Inc, valued at $1,309,087 using the latest closing price.
Johnson Alexander L, the of Caredx Inc, sale 21,557 shares at $32.58 during a trade that took place back on Aug 21 ’24, which means that Johnson Alexander L is holding 284,983 shares at $702,327 based on the most recent closing price.
Stock Fundamentals for CDNA
Current profitability levels for the company are sitting at:
- -0.18 for the present operating margin
- 0.74 for the gross margin
The net margin for Caredx Inc stands at -0.46. The total capital return value is set at -0.15. Equity return is now at value -43.02, with -29.35 for asset returns.
Based on Caredx Inc (CDNA), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 0.33.
Currently, EBITDA for the company is -82.08 million with net debt to EBITDA at 1.61. When we switch over and look at the enterprise to sales, we see a ratio of 3.63. The receivables turnover for the company is 4.69for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.10.
Conclusion
To sum up, Caredx Inc (CDNA) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
